CIK 0001802255
- Accelerated filer
Guardian Pharmacy Services, Inc.
Sign in to watch- Ticker
- GRDN
- Exchange
- NYSE
- Industry
- Retail-Drug Stores and Proprietary Stores
- FY end
- Dec 31
- Incorporated
- GA
- Entity type
- Operating
- EIN
- 200100834
- Phone
- +1 404-810-0089
- Business address
- 300 GALLERIA PARKWAY SE, SUITE 800, ATLANTA, GA, 30339
- Former names
- Guardian Pharmacy Services, Inc., Guardian Pharmacy, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-27 | Ackerman John Director | Option exercise | +1,413,939 | 3,863,806 | ||
| 2026-09-27 | Ackerman John Director | Option exercise | +471,057 | 1,287,237 | ||
| 2026-09-27 | Ackerman John Director | Option exercise · Class B Common Stock | −1,413,939 | 0 | ||
| 2026-09-27 | Ackerman John Director | Option exercise · Class B Common Stock | −471,057 | 0 | ||
| 2026-03-28 | Ackerman John Director | Option exercise | +1,413,939 | 2,449,867 | ||
| 2026-03-28 | Ackerman John Director | Option exercise | +471,057 | 816,180 | ||
| 2026-03-28 | Ackerman John Director | Option exercise · Class B Common Stock | −1,413,939 | 1,413,939 | ||
| 2026-03-28 | Ackerman John Director | Option exercise · Class B Common Stock | −471,057 | 471,057 | ||
| 2026-03-20 | Ackerman John Director | Sale | −827,636 | $29.68 | $24.6M | 1,035,928 |
| 2026-03-20 | Ackerman John Director | Sale | −275,728 | $29.68 | $8.2M | 345,123 |
| 2025-09-27 | Ackerman John Director | Option exercise | +1,413,940 | 1,863,564 | ||
| 2025-09-27 | Ackerman John Director | Option exercise | +471,057 | 620,851 | ||
| 2025-09-27 | Ackerman John Director | Option exercise · Class B Common Stock | −1,413,940 | 2,827,878 | ||
| 2025-09-27 | Ackerman John Director | Option exercise · Class B Common Stock | −471,057 | 942,114 | ||
| 2025-05-28 | Ackerman John Director | Sale | −150,998 | $20.16 | $3.0M | 449,624 |
| 2025-05-28 | Ackerman John Director | Sale | −50,305 | $20.16 | $1.0M | 149,794 |
| 2025-05-27 | Ackerman John Director | Sale | −813,318 | $20.16 | $16.4M | 600,622 |
| 2025-05-27 | Ackerman John Director | Sale | −270,958 | $20.16 | $5.5M | 200,099 |
| 2025-03-28 | Ackerman John Director | Option exercise | +1,413,940 | 1,413,940 | ||
| 2025-03-28 | Ackerman John Director | Option exercise | +471,057 | 471,057 |
Page 1 of 2 · 24 trades